tbuckley/cabot-search huggingface dataset:
SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
Authors: Catherine V. Donovan, Charles Rose, Kanna N. Lewis, Kristyn Vang, Nichole Stanley, Michael Motley, Clare C. Brown, Franklin John Gray, Joseph W. Thompson, Benjamin C. Amick, Mark L. Williams, Ebony Thomas, John Neatherlin, Namvar Zohoori, Austin Porter, Mike Cima
Journal: MMWR Morbidity and Mortality Weekly Report (2022)

Masks are effective at limiting transmission of SARS-CoV-2, the virus that causes COVID-19 (1), but the impact of policies requiring masks in school settings has not been widely evaluated (2-4). During fall 2021, some school districts in Arkansas implemented policies requiring masks for students in kindergarten through grade 12 (K-12). To identify any association between mask policies and COVID-19 incidence, weekly school-associated COVID-19 incidence in school districts with full or partial mask requirements was compared with incidence in districts without mask requirements during August 23-October 16, 2021. Three analyses were performed: 1) incidence rate ratios (IRRs) were calculated comparing districts with full mask requirements (universal mask requirement for all students and staff members) or partial mask requirements (e.g., masks required in certain settings, among certain populations, or if specific criteria could not be met) with school districts with no mask requirement; 2) ratios of observed-to-expected numbers of cases, by district were calculated; and 3) incidence in districts that switched from no mask requirement to any mask requirement were compared before and after implementation of the mask policy. Mean weekly district-level attack rates were 92-359 per 100,000 persons in the community* and 137-745 per 100,000 among students and staff members; mean student and staff member vaccination coverage ranged from 13.5% to 18.6%. Multivariable adjusted IRRs, which included adjustment for vaccination coverage, indicated that districts with full mask requirements had 23% lower COVID-19 incidence among students and staff members compared with school districts with no mask requirements. Observed-to-expected ratios for full and partial mask policies were lower than ratios for districts with no mask policy but were slightly higher for districts with partial policies than for those with full mask policies. Among districts that switched from no mask requirement to any mask requirement (full or partial), incidence among students and staff members decreased by 479.7 per 100,000 (p<0.01) upon implementation of the mask policy. In areas with high COVID-19 community levels, masks are an important part of a multicomponent prevention strategy in K-12 settings (5).
RISK OF COGNITIVE IMPAIRMENT AND ANTICOAGULANT USE ACROSS THE SPECTRUM OF ATRIAL FIBRILLATION BURDEN IN OLDER ADULTS: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
Authors: Romil Parikh, Wendy Wang, Michael Zhang, Faye Norby, Jeremy Van't Hof, Kunihiro Matsushita, Elsayed Z. Soliman, B. Gwen Windham, Thomas H. Mosley, James Pike, Bruce Wasserman, Michelle Johansen, Rebecca Gottesman, Alvaro Alonso, Lin Yee Chen
Journal: Journal of the American College of Cardiology (2022)
47P Prevalence of mutations in common tumour types in Northern England and utility of Experimental Cancer Medicine Centre (ECMC) CRUK Trial Finder
Authors: S.C.A. Rae, E. Plummer, L. Fitzgerald, L. Hogarth, A. Bridgewood, L. Brown-Schofield, J. Graham, Y. Drew, N. Haris, S. Bashir, R. Plummer, A. Greystoke
Journal: Annals of Oncology (2022)
TRENDS IN USE AND OUTCOMES OF INTRAVASCULAR IMAGING DURING PCI IN A REAL-WORLD US COHORT, 2008 - 2019
Authors: Heidi Lumish, Brandi L. Vollmer, Brian Bergmark, Kevin J. Croce, Eric Alexander Secemsky, Eric Alan Osborn, Rahul P. Sharma, Celina M. Yong, Muredach P. Reilly, Raj R. Makkar, Harlan M. Krumholz, Ziad Ali, Aakriti Gupta
Journal: Journal of the American College of Cardiology (2022)
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster
Authors: Sakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, Kith Pradhan, David G. Goldfarb, Angelica Barreto-Galvez, Alexander J. Silver, Jiahao Chen, Srabani Sahu, Shanisha Gordon-Mitchell, Gaurav S. Choudhary, Srinivas Aluri, Tushar D. Bhagat, Aditi Shastri, Cosmin A. Bejan, Shannon S. Stockton, Travis P. Spaulding, Victor Thiruthuvanathan, Hiroki Goto, Jeannine Gerhardt, Syed Hissam Haider, Arul Veerappan, Matthias Bartenstein, George Nwankwo, Ola Landgren, Michael D. Weiden, Jacqueline Lekostaj, Ryan Bender, Frederick Fletcher, Lee Greenberger, Benjamin L. Ebert, Ulrich Steidl, Britta Will, Anna Nolan, Advaitha Madireddy, Michael R. Savona, David J. Prezant, Amit Verma
Journal: Nature Medicine (2022)
A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts
Authors: Carlene L Zindl, Steven J Witte, Vincent A Laufer, Min Gao, Zongliang Yue, Karen M Janowski, Baiyi Cai, Blake F Frey, Daniel J Silberger, Stacey N Harbour, Jeffrey R Singer, Henrietta Turner, Frances E Lund, Bruce A Vallance, Alexander F Rosenberg, Trenton R Schoeb, Jake Y Chen, Robin D Hatton, Casey T Weaver
Journal: Immunity (2022)
THE USE OF ATENOLOL AND LOSARTAN IN REDUCING AORTIC DILATION IN PATIENTS WITH MARFAN SYNDROME A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Waleed Khokher, Saffa Iftikhar, Azizullah Beran, Cameron Burmeister, Nithin Kesireddy, Mohammad Altujjar, Modar Alom, Mohammed Mhanna, Jeremy Tomcho, Wasef Sayeh
Journal: Journal of the American College of Cardiology (2022)
UTILIZATION OF PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE IN CHIP-PCI IS ASSOCIATED WITH LOW RATES OF ADVERSE EVENTS WITHOUT SIGNIFICANTLY INCREASING LENGTH OF STAY OR PROCEDURE TIME: EXPERIENCE FROM A HIGH-VOLUME CENTER
Authors: Arber Kodra, Astha Tejpal, Ioanna Katsa, Jonathan Spagnola, Varinder P. Singh, Babak Hassid
Journal: Journal of the American College of Cardiology (2022)
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
Authors: Ajay K. Nooka, Uma Shanmugasundaram, Narayana Cheedarla, Hans Verkerke, Venkata V. Edara, Rajesh Valanparambil, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, Maryam Azeem, Julia Manalo, Jeffrey M. Switchenko, Andres Chang, Susanne L. Linderman, John D. Roback, Kavita M. Dhodapkar, Rafi Ahmed, Mehul S. Suthar, Andrew S. Neish, Madhav V. Dhodapkar
Journal: Journal of Clinical Oncology (2022)

Vaccine-induced neutralizing antibodies (nAbs) play a critical role in protection from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased risk of COVID-19-related mortality and exhibit variable serologic response to the vaccine. The capacity of vaccine-induced antibodies in these patients to neutralize SARS CoV-2 or its variants is not known.Sera from 238 patients with multiple myeloma (MM) undergoing SARS CoV-2 vaccination were analyzed. Antibodies against the SARS CoV-2 spike receptor-binding domain (RBD) and viral nucleocapsid were measured to detect serologic response to vaccine and environmental exposure to the virus. The capacity of antibodies to neutralize virus was quantified using pseudovirus neutralization assay and live virus neutralization against the initial SARS CoV-2 strain and the B1.617.2 (Delta) variant.Vaccine-induced nAbs are detectable at much lower rates (54%) than estimated in previous seroconversion studies in MM, which did not monitor viral neutralization. In 33% of patients, vaccine-induced antispike RBD antibodies lack detectable neutralizing capacity, including against the B1.617.2 variant. Induction of nAbs is affected by race, disease, and treatment-related factors. Patients receiving mRNA1273 vaccine (Moderna) achieved significantly greater induction of nAbs compared with those receiving BNT162b2 (Pfizer; 67% v 48%, P = .006).These data show that vaccine-induced antibodies in several patients with MM lack detectable virus-neutralizing activity. Vaccine-mediated induction of nAbs is affected by race, disease, vaccine, and treatment characteristics. These data have several implications for the emerging application of booster vaccines in immunocompromised hosts.
TIMING OF BIOPROSTHETIC VALVE FRACTURE IN RELATIONSHIP TO VALVE-IN-VALVE TRANSCATHETER AORTIC VALVE REPLACEMENT PROCEDURES
Authors: Santiago Garcia, Go Hashimoto, Robert Steffen, Muhammad Hammadah, Joao L. Cavalcante, Hirotomo Sato, Vinayak Nilkanth Bapat
Journal: Journal of the American College of Cardiology (2022)
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis
Authors: Hyogo Naoi, Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Yusuke Inoue, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Journal: Thorax (2022)

Patients with idiopathic pulmonary fibrosis (IPF) are at a high risk of lung cancer (LC). Antifibrotic therapy slows disease progression and possibly prolongs survival. However, whether antifibrotic therapy affects LC development in patients with IPF remains unknown. This multicentre retrospective study evaluated 345 patients with IPF. The incidence and prevalence of LC were significantly lower in patients with IPF receiving antifibrotic therapy than those not receiving. Subsequently, LC-related mortality was significantly lower in patients with IPF receiving antifibrotic therapy. These results suggest that antifibrotic therapy was possibly associated with a reduced risk of LC development in patients with IPF, which may be partly associated with its survival benefit.
Genetic Ancestry to Improve Precision of Race/Ethnicity–based Lung Function Equations in Children
Authors: Jonathan Witonsky, Jennifer R. Elhawary, Celeste Eng, José R. Rodríguez-Santana, Luisa N. Borrell, Esteban G. Burchard
Journal: American Journal of Respiratory and Critical Care Medicine (2022)

"Genetic Ancestry to Improve Precision of Race/Ethnicity–based Lung Function Equations in Children." American Journal of Respiratory and Critical Care Medicine, 205(6), pp. 725–727
LEFT VENTRICULAR EJECTION FRACTION AND OUTCOMES OF CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION
Authors: Bahadir Simsek, Spyridon Kostantinis, Judit Karacsonyi, Khaldoon Alaswad, Dimitrios I. Karmpaliotis, Lorenzo Azzalini, Wissam A. Jaber, Stéphane Rinfret, Farouc A. Jaffer, James W. Choi, Paul Poommipanit, Sevket Gorgulu, Philip B. Dattilo, Oleg Krestyaninov, Basem Elbarouni, Mitul P. Patel, Michalis Koutouzis, Alfredo R. Galassi, Kambis Mashayekhi, Ilias Nikolakopoulos, Evangelia Vemmou, Bavana V. Rangan, M. Nicholas Burke, Santiago Garcia, Emmanouil S. Brilakis
Journal: Journal of the American College of Cardiology (2022)
Abstract P3-01-14: A model incorporating axillary tail position on mammography for preoperative prediction of non-sentinel lymph node metastasis in patients with initial cN+ breast cancer after neoadjuvant chemotherapy
Authors: Kun Wang, Teng Zhu, Tingfeng Zhang
Journal: Cancer Research (2022)

Abstract Background and Objectives: Few models with good discriminative power have been constructed to predict the risk of non-sentinel lymph node (NSLN) metastasis in breast cancer prior to breast surgery after neoadjuvant chemotherapy (NAC). This study aimed to develop a new model for the prediction of NSLN metastasis in patients with initial clinical node positivity (cN+).Methods: The present study reviewed a total of 257 patients (179 in the training set and 78 in the testing set) with cN+ breast cancer who underwent both sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) following NAC. Univariate and multivariate analyses were used to select clinical factors affecting NSLN metastasis prior to breast surgery. A logistic regression model was developed based on these factors and the results of post-NAC axillary tail position on mammography (AT) and ultrasound (AUS).Results: Four factors with p&amp;lt;0.05 in the univariate analysis, including ycT0 (odds ratio [OR]: 4.84, 95% confidence interval [CI]: 2.13-11.91, p&amp;lt;0.001), clinical stage before NAC (OR: 2.68, 95% CI: 1.15-6.58, p=0.025), estrogen receptor (ER) expression (OR: 3.29, 95% CI: 1.39-8.39, p=0.009), and Her2 status (OR: 0.21, 95% CI: 0.08-0.50, p=0.001), were independent predictors of NSLN metastases. The clinical model based on the above data resulted in an AUC of 0.82 (95% confidence interval [CI]: 0.76-0.88) in the training set and 0.83 (95% CI: 0.74-0.92) in the validation set. The results of the post-NAC AUS and. AT were added to the clinical model to construct a clinical imaging model for the prediction of NSLN metastasis with an area under the curve of 0.87 (95% confidence interval [CI]: 0.81-0.93) in the training set and 0.89 (95% CI: 0.82-0.96) in the validation set.Conclusions: The present study incorporated the results of post-NAC AT and AUS with other clinal factors to develop a new model for the prediction of NSLN metastasis in patients with initial cN+ prior to breast surgery. This model performed excellently, allowing physicians to select patients for whom unnecessary ALND could be omitted after NAC. Citation Format: Kun Wang, Teng Zhu, Tingfeng Zhang. A model incorporating axillary tail position on mammography for preoperative prediction of non-sentinel lymph node metastasis in patients with initial cN+ breast cancer after neoadjuvant chemotherapy [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P3-01-14.
DEVELOPMENT OF A SCORING SYSTEM FOR PREDICTING HIGH RESIDUAL GRADIENT AT PRE-DISCHARGE ECHOCARDIOGRAPHY FOLLOWING TAVR
Authors: Houman Khalili, Amer N. Kadri, Thomas Pilgrim, Anthony A. Bavry, Taishi Okuno, Karim Al-Azizi, Thomas Waggoner, Sammy Elmariah, Brijeshwar Singh Maini, Philippe Pibarot, Amr E. Abbas
Journal: Journal of the American College of Cardiology (2022)
The trillion dollar vaccine gap
Authors: Simone Pecetta, Daniel Tortorice, Francesco Berlanda Scorza, Mariagrazia Pizza, Gordon Dougan, Richard Hatchett, Steve Black, David E. Bloom, Rino Rappuoli
Journal: Science Translational Medicine (2022)

New technologies and unprecedented public investment have transformed vaccine development and allowed fast delivery of safe and efficacious COVID-19 vaccines, mitigating the impact of the pandemic on health and the economy. A quantum change in public investment for vaccine development and widespread vaccine distribution are necessary to achieve global pandemic preparedness.
Dual-Phase 18F-Florbetaben PET/CT
Authors: Teodoro Rudolphi-Solero, Eva María Triviño Ibáñez, Tarik Aroui, Rocío Hervás Navidad, Manuel Gómez-Río
Journal: Clinical Nuclear Medicine (2021)

Abstract Dual-phase amyloid PET is considered a useful protocol to study patients with cognitive impairment. Early-phase 18 F-florbetaben PET/CT has been proposed as a surrogate of 18 F-FDG PET/CT providing information related to regional brain perfusion. We report the case of a 61-year-old woman referred to the cognitive impairment unit for study, preliminary diagnosed as probable Alzheimer disease. The dual-phase 18 F-florbetaben PET/CT was shown as the main finding, no uptake in the left anterior thalamus. Memory and language symptoms have been described as primary clinical features of anterior thalamic infarctions that could be confused with the main manifestations of Alzheimer disease.
IDEAL CARDIOVASCULAR HEALTH TRAJECTORIES AND SUBSEQUENT CARDIOVASCULAR DISEASE AND MORTALITY: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)
Authors: Qicong Sheng, Jie Ding, Yumin Gao, Reshmi J.S. Patel, Wendy S. Post, Seth Shay Martin
Journal: Journal of the American College of Cardiology (2022)
LONG-TERM OUTCOMES WITH DRUG-ELUTING BALLOON FOR THE TREATMENT OF IN-STENT RESTENOSIS AND DE NOVO LESIONS: THE NOBITRE REGISTRY
Authors: Monica Verdoia, Filippo Zilio, Marta Francesca Brancati, Orazio Viola, Pier Luigi Soldà, Giuseppe De Luca
Journal: Journal of the American College of Cardiology (2022)
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective
Authors: Vincent Cottin, Sara Tomassetti, Claudia Valenzuela, Simon L. F. Walsh, Katerina M. Antoniou, Francesco Bonella, Kevin K. Brown, Harold R. Collard, Tamera J. Corte, Kevin R. Flaherty, Kerri A. Johannson, Martin Kolb, Michael Kreuter, Yoshikazu Inoue, R. Gisli Jenkins, Joyce S. Lee, David A. Lynch, Toby M. Maher, Fernando J. Martinez, Maria Molina-Molina, Jeff L. Myers, Steven D. Nathan, Venerino Poletti, Silvia Quadrelli, Ganesh Raghu, Sujeet K. Rajan, Claudia Ravaglia, Martine Remy-Jardin, Elisabetta Renzoni, Luca K. Richeldi, Paolo Spagnolo, Lauren Troy, Marlies Wijsenbeek, Kevin C. Wilson, Wim Wuyts, Athol U. Wells, Christopher J. Ryerson
Journal: American Journal of Respiratory and Critical Care Medicine (2022)

Background: When considering the diagnosis of idiopathic pulmonary fibrosis (IPF), experienced clinicians integrate clinical features that help to differentiate IPF from other fibrosing interstitial lung diseases, thus generating a "pre-test" probability of IPF. The aim of this international working group perspective was to summarize these features using a tabulated approach similar to chest HRCT and histopathologic patterns reported in the international guidelines for the diagnosis of IPF, and to help formally incorporate these clinical likelihoods into diagnostic reasoning to facilitate the diagnosis of IPF. Methods: The committee group identified factors that influence the clinical likelihood of a diagnosis of IPF, which was categorized as a pre-test clinical probability of IPF into "high" (70-100%), "intermediate" (30-70%), or "low" (0-30%). After integration of radiological and histopathological features, the post-test probability of diagnosis was categorized into "definite" (90-100%), "high confidence" (70-89%), "low confidence" (51-69%), or "low" (0-50%) probability of IPF. Findings: A conceptual Bayesian framework was created, integrating the clinical likelihood of IPF ("pre-test probability of IPF") with the HRCT pattern, the histopathology pattern when available, and/or the pattern of observed disease behavior, into a "post-test probability of IPF." The diagnostic probability of IPF was expressed using an adapted diagnostic ontology for fibrotic interstitial lung diseases. Interpretation: The present approach will help incorporate the clinical judgment into the diagnosis of IPF, thus facilitating the application of IPF diagnostic guidelines and, ultimately improving diagnostic confidence and reducing the need for invasive diagnostic techniques.
MYOCARDIAL DAMAGE IN CHRONIC TOTAL CORONARY OCCLUSION TERRITORY COLLATERALIZED BY AN INFARCT-RELATED ARTERY: DEFINING DOUBLE JEOPARDY
Authors: Yvemarie Somsen, Rocco Giunta, Ruben Willem De Winter, Stefan Schumacher, Pepijn Van Diemen, Ruurt Jukema, Wynand Stuijfzand, Ibrahim Danad, Niels Verouden, Alexander Nap, Alfredo R. Galassi, José P. Henriques, Paul Knaapen
Journal: Journal of the American College of Cardiology (2022)
A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis
Authors: Qing Zhang, Yun-Ze Zhao, Hong-Hao Ma, Dong Wang, Lei Cui, Wei-Jing Li, Ang Wei, Chan-Juan Wang, Tian-You Wang, Zhi-Gang Li, Rui Zhang
Journal: Blood (2022)
ASSESSING THE PREVALENCE AND OUTCOMES OF MICROVASCULAR DISEASE IN A LARGE APPALACHIAN HEALTH SYSTEM
Authors: Bandar Alyami, Shelby Jones, Muchi Ditah Chobufo, Zain Alzahrani, Saikrishna Patibandla, Mohamed Alhajji, Elizabeth Marshall, Madhavi Kadiyala, James D. Mills, Gary D. Marano, Yasmin Hamirani
Journal: Journal of the American College of Cardiology (2022)
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study
Authors: Ole Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Iversen, Kamille Fogh, Jacob Bodilsen, Mette Iversen, Lene Surland Knudsen, Vibeke Klastrup, Fredrikke Dam Larsen, Sidsel Dahl Andersen, Astrid Korning Hvidt, Signe Rode Andreasen, Lone Wulff Madsen, Susan Olaf Lindvig, Anne Øvrehus, Sisse Rye Ostrowski, Christiane Abildgaard, Charlotte Matthews, Tomas O. Jensen, Dorthe Raben, Christian Erikstrup, Thea K. Fischer, Martin Tolstrup, Lars Østergaard, Jens Lundgren
Journal: Clinical Microbiology and Infection (2022)

To identify individual characteristics associated with serological COVID-19 vaccine responsiveness and the durability of vaccine-induced antibodies.Adults without history of SARS-CoV-2 infection from the Danish population scheduled for SARS-CoV-2 vaccination were enrolled in this parallel group, phase 4 study. SARS-CoV-2 Spike IgG and Spike-ACE2-receptor-blocking antibodies were measured at days 0, 21, 90, and 180. Vaccine responsiveness was categorized according to Spike IgG and Spike-ACE2-receptor-blocking levels at day 90 after first vaccination. Nondurable vaccine response was defined as day-90 responders who no longer had significant responses by day 180.Of 6544 participants completing two vaccine doses (median age 64 years; interquartile range: 54-75), 3654 (55.8%) received BTN162b2, 2472 (37.8%) mRNA-1273, and 418 (6.4%) ChAdOx1 followed by an mRNA vaccine. Levels of both types of antibodies increased from baseline to day 90 and then decreased to day 180. The decrease was more pronounced for levels of Spike-ACE2-receptor-blocking antibodies than for Spike IgG. Proportions with vaccine hyporesponsiveness and lack of durable response were 5.0% and 12.1% for Spike IgG and 12.7% and 39.6% for Spike-ACE2-receptor-blocking antibody levels, respectively. Male sex, vaccine type, and number of comorbidities were associated with all four outcomes. Additionally, age ≥75 years was associated with hyporesponsiveness for Spike-ACE2-receptor-blocking antibodies (adjusted odds ratio: 1.59; 95% confidence interval: 1.25-2.01) but not for Spike IgG.Comorbidity, male sex, and vaccine type were risk factors for hyporesponsiveness and nondurable response to COVID-19 vaccination. The functional activity of vaccine-induced antibodies declined with increasing age and had waned to pre-second-vaccination levels for most individuals after 6 months.
Local feedback inhibition tightly controls rapid formation of hippocampal place fields
Authors: Sebi V Rolotti, Mohsin S Ahmed, Miklos Szoboszlay, Tristan Geiller, Adrian Negrean, Heike Blockus, Kevin C Gonzalez, Fraser T Sparks, Ana Sofia Solis Canales, Anna L Tuttman, Darcy S Peterka, Boris V Zemelman, Franck Polleux, Attila Losonczy
Journal: Neuron (2022)
SHORT TERM OUTCOMES OF SAVR VERSUS TAVR WITH BARIATRIC SURGERY: POPULATION BASED STUDY
Authors: Omar Abdelfattah, Abdelrahman Abushouk, Anas M. Saad, Toshiaki Isogai, Shashank Shekhar, Mohamed M. Gad, Samir R. Kapadia
Journal: Journal of the American College of Cardiology (2022)
Error in Table 2 and Figure 1
Journal: JAMA Network Open (2022)

Richard K. Kwok, PhD; W. Braxton Jackson II, MPH; Matthew D. Curry, MA; Patricia A. Stewart, PhD; John A. McGrath, MA; Mark Stenzel, MS; Tran B. Huynh, PhD; Caroline P. Groth, PhD; Gurumurthy Ramachandran, PhD; Sudipto Banerjee, PhD; Gregory C. Pratt, PhD; Aubrey K. Miller, MD, MPH; Xian Zhang, PhD; Lawrence S. Engel, PhD; Dale P. Sandler, PhD
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Authors: Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, Mattia Pedotti, Andrea Doni, Francesco Scavello, Sarah N. Mapelli, Marina Sironi, Chiara Perucchini, Luca Varani, Milos Matkovic, Andrea Cavalli, Daniela Cesana, Pierangela Gallina, Nicoletta Pedemonte, Valeria Capurro, Nicola Clementi, Nicasio Mancini, Pietro Invernizzi, Rafael Bayarri-Olmos, Peter Garred, Rino Rappuoli, Stefano Duga, Barbara Bottazzi, Mariagrazia Uguccioni, Rosanna Asselta, Elisa Vicenzi, Alberto Mantovani, Cecilia Garlanda
Journal: Nature Immunology (2022)